ChemicalBook >> CAS DataBase List >>Gabexate mesylate

Gabexate mesylate

CAS No.
56974-61-9
Chemical Name:
Gabexate mesylate
Synonyms
FOY;Agalit;FOY-007;Arodate;Megacert;MEGACART;GABEXATE;FOY-S 983;Mesyl Gabexate;gabexatomesilato
CBNumber:
CB4258638
Molecular Formula:
C17H27N3O7S
Molecular Weight:
417.48
MDL Number:
MFCD00210299
MOL File:
56974-61-9.mol
Last updated:2023-06-30 15:45:59

Gabexate mesylate Properties

Melting point 89.0 to 93.0 °C
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility Soluble in DMSO (up to 50 mg/ml) or in Water (up to 50 mg/ml).
form solid
color Off-white
Water Solubility Soluble to 100 mM in water
Merck 14,4320
Stability Stable for 2 years from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20°C for up to 1 month.
InChIKey DNTNDFLIKUKKOC-UHFFFAOYSA-N
CAS DataBase Reference 56974-61-9(CAS DataBase Reference)
FDA UNII E3Q07L0649

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS08
Signal word  Warning
Hazard statements  H373
Precautionary statements  P260-P314-P501
Hazard Codes  Xn
RIDADR  3077
WGK Germany  2
RTECS  DG2800800
HS Code  29252900
Toxicity LD50 in mice (mg/kg): 8000 orally; 4700 s.c.; 25 i.v. (Fujita)

Gabexate mesylate price More Price(32)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich G2417 Gabexate mesylate analytical standard, for drug analysis 56974-61-9 5mg $206 2022-05-15 Buy
TCI Chemical G0464 Gabexate Mesylate >97.0%(N) 56974-61-9 1g $193 2024-03-01 Buy
TCI Chemical G0464 Gabexate Mesylate >97.0%(N) 56974-61-9 5g $490 2021-12-16 Buy
Cayman Chemical 23767 Gabexate (mesylate) ≥98% 56974-61-9 5mg $81 2024-03-01 Buy
Cayman Chemical 23767 Gabexate (mesylate) ≥98% 56974-61-9 10mg $96 2024-03-01 Buy
Product number Packaging Price Buy
G2417 5mg $206 Buy
G0464 1g $193 Buy
G0464 5g $490 Buy
23767 5mg $81 Buy
23767 10mg $96 Buy

Gabexate mesylate Chemical Properties,Uses,Production

Description

Gabexate mesylate (56974-61-9) is a? serine protease inhibitor inhibiting plasmin, kallikrein, thrombin as well as trypsin, which attenuates pancreatic fibrosis.1? Reduces weight gain and improves metabolism in obese rodent models.2?In clinical use (in Japan) for pancreatitis.3?Inhibits influenza virus replication in human tracheal epithelial cells.4?Reduces infection of Calu-3 lung cells by SARS-CoV-2 (responsible for COVID-19) via inhibition of the serine protease TMPRSS2 required for viral spike protein priming.5

Chemical Properties

Gabexate mesylate is supplied as a crystalline solid. A stock solution may be made by dissolving the gabexate (mesylate) in the solvent of choice. Gabexate (mesylate) is soluble in organic solvents such as DMSO and dimethyl formamide, which should be purged with an inert gas. The solubility of gabexate (mesylate) in these solvents is approximately 25 mg/ml.
Gabexate is a competitive inhibitor of serine proteases that inhibits human thrombin, urokinase, plasmin, and Factor Xa (Kis = 0.97, 1.3, 1.6, and 8.5 μM, respectively). It also inhibits bovine thrombin, Factor Xa, and trypsin, and porcine plasma kallikrein (Kis = 1.4, 2.1, 2.6, and 0.2 μM, respectively). In vitro, gabexate inhibits clotting activity of thrombin (IC50 = 10 μM).In vivo, it inhibits fibrin formation in rats when administered at a continuous infusion of 120 μmol/kg per hour. Gabexate inhibits LPS-stimulated TNF-α production from monocytes by inhibiting binding of NF-κB and activator protein 1 (AP-1) to target sites and inducing degradation of IκBα.

Originator

Gabexate Mesylate,Shangai Lansheng

Uses

Gabexate Mesylate is a serine protease inhibitor. Gabexate Mesylate inhibits trypsin, plasmin, plasma kallikrein and thrombin. Gabexate Mesylate inhibits lipopolysaccharide-induced tumor necrosis factor-α (TNF-α) production through nuclear factor-κB and activator protein-1 activation. Neuroresearch & Neuroprotective Product.

Uses

Pancreatitis;Serine protease inhibitor.
Gabexate Mesylate is a serine protease inhibitor with IC50 of 0.19 μM which is used therapeutically in the treatment of pancreatitis and disseminated intravascular coagulation.

Preparation

Guanidinocaproic acid p-tosyl salt and thionyl chloride were mixed together toreact at the room temperature. An endothermic reaction occurred and thecaproic acid gradually dissolved. Then the reaction mixture was left standingfor 1 to 2 h and was extracted with ether. The lower oily layer and the etherlayer were separated from each other and the lower layer was repeatedlywashed with ether. Then the oily substance (caproic acid chloride) was addedwith benzoic acid ethyl ester in tetrahydrofuran, and the mixture was stirred.After the mixture became a uniform solution, of pyridine were graduallyadded. An exothermic reaction occurred and an oily substance came to beseparated in the lower layer. After the completion of the reaction, the oilysubstance was washed with water and then recrystallized from hot water onceor twice. Thus 4-(6-guanidino-hexanoyloxy)-benzoic acid ethyl ester salt wasobtained as white crystals.
To obtained the base 4-(6-guanidino-hexanoyloxy)-benzoic acid ethyl esterthe 4-(6-guanidino-hexanoyloxy)-benzoic acid ethyl ester salt must be treatedby, for example, sodium hydroxide.
In practice it is usually used as gabexate Mesylate.

Definition

ChEBI: Gabexate methanesulfonate is a methanesulfonate salt, a member of guanidines and a benzoate ester.

Manufacturing Process

Guanidinocaproic acid p-tosyl salt and thionyl chloride were mixed together to react at the room temperature. An endothermic reaction occurred and the caproic acid gradually dissolved. Then the reaction mixture was left standing for 1 to 2 h and was extracted with ether. The lower oily layer and the ether layer were separated from each other and the lower layer was repeatedly washed with ether. Then the oily substance (caproic acid chloride) was added with benzoic acid ethyl ester in tetrahydrofuran, and the mixture was stirred. After the mixture became a uniform solution, of pyridine were gradually added. An exothermic reaction occurred and an oily substance came to be separated in the lower layer. After the completion of the reaction, the oily substance was washed with water and then recrystallized from hot water once or twice. Thus 4-(6-guanidino-hexanoyloxy)-benzoic acid ethyl ester salt was obtained as white crystals.
To obtained the base 4-(6-guanidino-hexanoyloxy)-benzoic acid ethyl ester the 4-(6-guanidino-hexanoyloxy)-benzoic acid ethyl ester salt must be treated by, for example, sodium hydroxide.
In practice it is usually used as mesylate.

Therapeutic Function

Enzyme inhibitor

Mechanism of action

Gabexate mesilate (FOY-007) is a protease inhibitor with a broad spectrum inhibiting not only trypsin and kallikrein, but also plasmin, thrombin,factor Xa, elastase, complement 1 (C1), esterase and phospholipase A2. Prophylactic application of FOY-007 or Camostat mesilate (FOY-305) showed some beneficial effect in CDEinduced pancreatitis, cerulein-induced panceratitis and sodium taurocholate-induced panceratitis. The therapeutic effect of FOY-007 in acute panceratitis has been ascribed to its inhibition of pancreatic enzyme activity, like trypsin, thus preventing autodigestion.

Clinical Use

Gabexate mesylate inhibits proteases and suppresses endothelial cell injury and may be used to treat DIC ascribed to various kinds of diseases.
Therapeutic Function: Enzyme inhibitor

storage

Desiccate at RT

References

1) Gibo?et al.?(2005),?Camostat Mesilate Attenuates Pancreatic Fibrosis via Inhibition of Monocytes and Pancreatic Stellate Cells Activity; Lab Invest.,?85?75 2) Albarazanji?et al.?(2019),?Intestinal Serine Protease Inhibition Increases FGF21 and Improves Metabolism in Obese Mice; Am. J. Physiol. Gastrointest. Liver Physiol.,?316?G653 3) Ueda?et al.?(2015),?The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease Through Its Antioxidant Effects; Nephron,?129?223 4) Yamaya?et al.?(2015),?The Serine Protease Inhibitor Camostat Inhibits Influenza Virus Replication and Cytokine Production in Primary Cultures of Human Tracheal Epithelial Cells; Pulm. Pharmacol. Ther., 33?66 5) Hoffmann?et al.?(2020),?SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor; Cell,?181?271

Gabexate mesylate Preparation Products And Raw materials

Global( 245)Suppliers
Supplier Tel Email Country ProdList Advantage
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714 fandachem@gmail.com China 9348 55
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845 sales@amoychem.com China 6387 58
Beijing Yibai Biotechnology Co., Ltd
0086-182-6772-3597 sales04@yibaibiotech.com CHINA 419 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49390 58
Shaanxi Dideu Medichem Co. Ltd
+86-29-87569265 +86-18612256290 1056@dideu.com China 3581 58
SIMAGCHEM CORP
+86-13806087780 sale@simagchem.com China 17367 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58

View Lastest Price from Gabexate mesylate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Gabexate mesylate USP/EP/BP pictures 2021-08-04 Gabexate mesylate USP/EP/BP
56974-61-9
US $1.10 / g 1g 0.999 100 Tons min Dideu Industries Group Limited
Gabexate mesylate pictures 2021-07-20 Gabexate mesylate
56974-61-9
US $1.00-1.00 / KG 1g 99% 50tons Shaanxi Dideu Medichem Co. Ltd
Gabexate mesylate pictures 2021-07-13 Gabexate mesylate
56974-61-9
US $15.00-10.00 / KG 1KG 99%+ HPLC Monthly supply of 1 ton Zhuozhou Wenxi import and Export Co., Ltd
  • Gabexate mesylate pictures
  • Gabexate mesylate
    56974-61-9
  • US $15.00-10.00 / KG
  • 99%+ HPLC
  • Zhuozhou Wenxi import and Export Co., Ltd

Gabexate mesylate Spectrum

4-[[6-[(Amino-iminomethyl)amino]-1-oxohexyl]oxy]benzoic acid ethyl ester monomethanesulfonate Gapexate Mesylate Megacert Agalit Arodate FOY-007 FOY-S 983 Mesyl Gabexate Gabexate Mesylate API 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-benzoic acid ethyl ester,methanesulfonate (1:1) benzoicacid,4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-,ethylester,mo ethylp-(6-guanidinohexanoyloxy)benzoatemethanesulfonate gabexatomesilato p-hydroxybenzoicacidethylester6-guanidinohexanoatemesilate MEGACART GABEXATE GABEXATE MESILATE GABEXATE MESYLATE GABEXATE METHANESULFONATE GABEXATE MONOMETHANESULFONATE FOY Gabexate Mysylate 4-[[6-[(AMINOIMINOMETHYL)AMINO]-1-OXOHEXYL]OXY]-BENZOIC ACID ETHYL ESTER MESYLATE 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxyl]benzoic acid ethyl ester mesylate salt 4[[6-[(AMINOIMINOMETHYL)AMINO]-1-OXOHEXYL]OXYL]BENZOIC ACID ETHYL ESTER MONOMETHANESULFONATE Gabexate mesylate, 97%, serine protease inhibitor 4-[6-(diaminomethylideneamino)-1-oxohexoxy]benzoic acid ethyl ester GabexateMesylate> Gabexate Mesilate RS GABEXATE MESYLATE,56974-61-9 Gabexate mesylate USP/EP/BP Gabexate Mesylater Ethyl 4-((6-guanidinohexanoyl)oxy)benzoate methanesulfonate Gabexate Mesylate (Megacert 56974-61-9 C16H23N3O4CH3SO3H C16H23N3O4CH4O3SC17H C16H23N3O4CH4O3S C17H27N3O7S C16H23N3O4CH4O3SC17H27N3O7S Analytical Enzymes Biochemicals and Reagents BioChemical Enzymes, Inhibitors, and Substrates Trypsin Inhibitors Aromatics Inhibitors Intermediates & Fine Chemicals Pharmaceuticals Other APIs Benzoic acid Active Pharmaceutical Ingredients